Skip to content
Screener

Solid Biosciences Inc. SLDB Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$146.15M+75.8%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%
Scholar Rock logo
Scholar RockSRRK
$2.77M-6.6%
Biogen logo
BiogenBIIB
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Wave Life Sciences logo
Wave Life SciencesWVE

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.4M-37.6%
Net income-$54.8M-38.8%
EPS (diluted)-$0.38+9.5%

Balance sheet

See full
Cash & equivalents$159.4M+14.7%
Total debt$20.2M-12.6%
Total equity$374.1M+44.8%
Total assets$420.6M+36.4%

Cash flow

See full
Operating cash flow-$52.6M-40.6%
CapEx$150.0K-60.2%
Free cash flow-$52.7M-39.6%

Valuation

See full
Market cap$917.85M+94.8%
Enterprise value$778.61M+119%

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-65.5%-2.5pp
Debt / equity0.1×0.0×
Current ratio13.8×+4.5×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-337935
Line itemJune 30, 2026December 31, 2025
Non-current assets:
Operating lease, right-of-use assets20,66721,924
Property and equipment, net3,9594,169
Other non-current assets138223
Restricted cash, net of current portion708768
Total non-current assets25,47227,084
Total assets$420,580$232,540
Liabilities and Stockholders’ Equity

Item 1. Financial Statements (unaudited)

FAQ

What is Solid Biosciences Inc.'s deferred tax assets and other non-current assets?
Solid Biosciences Inc. (SLDB) reported deferred tax assets and other non-current assets of $138K in Q2 2026.
How has Solid Biosciences Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Solid Biosciences Inc.'s deferred tax assets and other non-current assets decreased by 50.4% year-over-year, from $278K to $138K.
What is the long-term trend for Solid Biosciences Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s deferred tax assets and other non-current assets has grown at a 1.3% compound annual growth rate (CAGR), from $209K to $223K.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Solid Biosciences Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude